J&J’s $40 Billion Kenvue Stock Swap: What You Need to Know Finances August 3, 2023 [ad_1] This copy is in your private, non-commercial use solely. To order presentation-ready copies for distribution to your colleagues, shoppers…
Halozyme sees no impact on royalties after EU body revokes J&J’s Darzalex patent Markets March 15, 2023 [ad_1] miteman Halozyme Therapeutics (NASDAQ:HALO) mentioned the Opposition Division of the European Patent Workplace revoked a Janssen’s European Patent associated…
